Philogen philogen.com


Public lists: Eye Health (698)

Philogen is a Swiss-Italian integrated biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders.

Philogen is a Swiss-Italian integrated biotechnology company that develops biopharmaceuticals for the treatment of angiogenesis-related disorders.

Company (Alive / Active)

Phone: (+39) 0577.1781.6

Fax:

Via Bellaria, 35

Sovicille, 53018
Italy

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Philogen $0M Mar 19, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Philogen Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antigen associated with the neovasculature of tumour metastases Oct 05, 2015 Feb 20, 2018 Patent
Anti-ed-a immunoconjugates for inflammatory bowel disease Oct 03, 2012 Jul 04, 2017 Patent
Il-12 immunoconjugate Jul 24, 2012 Feb 28, 2017 Patent
Antigen associated with rheumatoid arthritis Jun 05, 2012 Jan 31, 2017 Patent
Sequential antibody therapy Jun 22, 2012 Jan 24, 2017 Patent
See all 41 patents